News

MedPage Today on MSN15h
Novel Smoking Cessation Drug Clears Last Hurdle Before FDA
The prior ORCA-V1 trial showed efficacy of cytisinicline for vapers looking to quit. For smokers, the ORCA-2 trial showed ...
New drug for Parkinson’s shown to be effective in clinical trials: 'Very encouraged'
A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...
New Scientist on MSN15d
Drugs like Ozempic and Wegovy could significantly cut dementia risk
Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
New Scientist25d
GLP-1 drugs are only the start – the powerful drugs to expect next
The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating some of our most difficult conditions ...
Medscape16d
Why a Placebo May Work Better When You Know It’s a Placebo
Study participants see significant relief from PMS symptoms even though they know they are taking a placebo. Here’s how ‘open-label’ placebos work.
Ozempic, other semaglutides linked to hair loss: Here's what to know
Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.
Experimental drug shown to slow multiple sclerosis disability
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
Medical Xpress29d
Open-label placebo appears to reduce premenstrual symptoms, study suggests
Get Instant Summarized Text (Gist) Open-label placebos (OLPs) significantly reduce premenstrual syndrome (PMS) symptoms when women are informed about the placebo nature of the treatment. In a ...